Cargando…
Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma
INTRODUCTION: Benralizumab, an interleukin-5 receptor alpha–directed cytolytic anti-eosinophil monoclonal antibody, was recently approved as add-on maintenance treatment for patients aged 12 years and older with uncontrolled asthma with eosinophilic inflammation. METHODS: Pharmacokinetic (PK) data f...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584252/ https://www.ncbi.nlm.nih.gov/pubmed/30854591 http://dx.doi.org/10.1007/s40262-019-00738-4 |